SciELO - Scientific Electronic Library Online

 
vol.23 issue3Anti-TNF Withdrawal in Inflammatory Bowel DiseaseVisceral Angioedema Induced by Angiotensin Converting Enzyme Inhibitor: Case Report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


GE-Portuguese Journal of Gastroenterology

Print version ISSN 2341-4545

Abstract

OLIVEIRA, Ana Maria et al. Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor. GE Port J Gastroenterol [online]. 2016, vol.23, n.3, pp.162-165. ISSN 2341-4545.  https://doi.org/10.1016/j.jpge.2015.09.008.

Visceral angioedema is a rare complication of therapy with angiotensin-converting enzyme (ACE) inhibitors. Clinical presentation includes nausea, vomiting, abdominal pain and diarrhea. Early detection of this entity can prevent recurrent episodes and unnecessary invasive procedures, including surgery. This article describes a 46-year-old-woman who presented to the emergency department with abdominal pain, associated with nausea and vomiting. She had been taking ramipril for 15 days. A computed tomography was performed which revealed thickening of a jejunal segment, with submucosal edema. ACE inhibitor-associated angioedema was suspected and the medication was discontinued, with resolution of symptoms in 48 h. After 7 months of follow-up, the patient is asymptomatic. Despite of its rarity, ACE inhibitor-induced small-bowel angioedema should be included in the differential diagnosis when patients receiving ACE inhibitor therapy present with abdominal complaints.

Keywords : Angioedema; Angiotensin-Converting Enzyme Inhibitors; Viscera.

        · abstract in Portuguese     · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License